Skip to main content

Pinched Vagus Nerve in the Neck: Guide to Symptoms, Causes & Assessment Released

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Nurosym has released new guidance on why vagus-related neck symptoms may be more complex than they seem, with research pointing to a broader picture that could include a role for auricular neuromodulation.

-- Nurosym has released a guide examining symptoms adults may associate with a pinched vagus nerve in the neck and why physical compression may not always explain them. The resource explores how neck-related factors, inflammation, and changes in autonomic function may intersect.

More information is available at https://nurosym.com/blogs/articles/pinched-vagus-nerve-in-the-neck-symptoms

The guide comes at a time when growing interest in the vagus nerve is drawing more attention to symptoms people may associate with it. With “pinched vagus nerve” used to describe experiences ranging from throat tightness and swallowing difficulty to dizziness and digestive changes, understanding what may be happening is rarely as simple as locating a physically trapped nerve.

True structural compression of the vagus nerve in the neck is uncommon, according to the guide. Research is exploring how cervical tension, inflammation and changes in autonomic function may contribute to the wider picture, opening the discussion beyond a solely structural explanation.

That distinction also broadens the approaches researchers are examining. Alongside appropriate cervical care and practices such as pacing and controlled breathing, non-invasive vagus nerve stimulation is being studied as another way of influencing vagus-related pathways without directly stimulating the nerve in the neck.

One approach is auricular neuromodulation, which applies gentle electrical pulses through areas of the outer ear where a branch of the vagus nerve reaches the skin. Nurosym uses Parasym's proprietary AVNT™ waveform to deliver this form of non-invasive vagus nerve stimulation.

The technology has been tested in randomised, placebo-controlled studies. Parasym's wider research programme includes 60+ completed clinical studies and 100+ ongoing clinical studies as it continues to grow its research base, alongside 150+ research partners.

The guide presents these symptoms as part of a complex picture that may involve several interacting factors and approaches to support. It also encourages readers with persistent or concerning symptoms to seek qualified medical assessment. The full guide and further information are available at https://nurosym.com/

Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as medical claims or guaranteed individual outcomes. Nurosym is a CE-marked medical device in Europe.

Contact Info:
Name: PR Team
Email: Send Email
Organization: Nurosym by Parasym
Address: 18 Saint Cross Street 4th Floor, London, England EC1N 8UN, United Kingdom
Website: https://nurosym.com/

Source: PressCable

Release ID: 89206180

Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  254.08
-4.50 (-1.74%)
AAPL  342.96
+1.69 (0.50%)
AMD  570.82
-34.71 (-5.73%)
BAC  51.39
-2.57 (-4.76%)
GOOG  343.65
-5.87 (-1.68%)
META  737.54
-24.96 (-3.27%)
MSFT  533.69
-9.76 (-1.80%)
NVDA  221.30
-7.22 (-3.16%)
ORCL  130.55
-12.65 (-8.83%)
TSLA  367.16
-8.07 (-2.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.